StemPrintER

About AccuStem Sciences

AccuStem Sciences is a UK-based, clinical-stage diagnostics company developing innovative genomic tools for cancer detection and treatment guidance. The company is advancing its StemPrintER platform and expanding into blood-based testing through partnerships. Led by an experienced management team with deep oncology diagnostics expertise, AccuStem is positioning itself to address the growing need for precision oncology solutions, though it faces the typical risks of an early-stage company in a competitive and capital-intensive sector.

Therapeutic Areas